Christie Hospital NHS Foundation Trust

Manchester, England M20 4BX

0 studies enrolling now · 2 studies all time

What they study most

Indolent Non-Hodgkin's Lymphomas, Prostate Cancer

Studies at this site

• Efficacy and Safety of Idelalisib (GS-1101) in Combination With Bendamustine and Rituximab for Previously Treated Indolent Non-Hodgkin Lymphomas — Stopped early
• Comparison of Cabazitaxel/Prednisone Alone or in Combination With Custirsen for 2nd Line Chemotherapy in Prostate Cancer — Completed